Key result
The Tenth Annual Ion Channel Retreat covered key subjects in the ion channel industry, including disease targets, screening technologies, and cardiac safety.
Key points are not available for this paper at this time.
Highlights ion channel trends for drug discovery; leaves open translation to cardiac safety protocols pending validation.
Ten years after Aurora Biomed (Vancouver, British Columbia, Canada) hosted the inaugural Ion Channel Retreat, this event is recognized as a leading conference for ion channel researchers. Held annually in Vancouver, this meeting consistently provides an outlet for researchers to share their findings while learning about new concepts, methods, and technologies. Researchers use this forum to discuss and debate a spectrum of topics from ion channel research and technology to drug discovery and safety. The Retreat covered key subjects in the ion channel industry, including ion channels as disease targets, transient receptor protein channels as pain and disease targets, ion channels as pain targets, ion channel structure and function, ion channel screening technologies, cardiac safety and toxicology, and cardiac function and pharmacology.
No takes yet. Share an insight, caveat, or question.
Kimlicka et al. (2013) studied this question. The Tenth Annual Ion Channel Retreat covered key subjects in the ion channel industry, including disease targets, screening technologies, and cardiac safety.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: